Prof. Gang Chen: Pioneer in Complex Kidney Re-Transplantation & Pediatric Renal Care at Tongji Hospital

1. Clinical Leadership: At the Helm of China's Premier Transplant Institute

Professor Gang Chen is widely regarded as one of China’s leading authorities in complex renal transplantation and clinical transplant immunology. Based at Tongji Hospital’s Institute of Organ Transplantation—the birthplace of modern organ transplantation in China and an officially designated National Clinical Research Center—Professor Chen has dedicated his career to expanding the boundaries of surgical feasibility for end-stage renal disease (ESRD) patients previously categorized as untransplantable.

Under his leadership, the renal transplantation team at Tongji Hospital handles immense case volumes, delivering long-term graft and patient survival rates that rival the foremost academic medical centers in North America and Western Europe, particularly in anatomically difficult and immunologically high-risk patient cohorts.

2. Primary Clinical Focus & High-Complexity Procedures

Professor Gang Chen's surgical and medical practice focuses on tertiary-level referral cases and ultra-complex renal grafting:

• Highly Sensitized Kidney Transplantation: Advanced management of patients with broad panel-reactive antibodies (PRA > 50%–80%) and positive crossmatches through customized pre-transplant desensitization regimens incorporating plasmapheresis, intravenous immunoglobulin, and novel targeted B-cell/plasma cell inhibitors.
• Multi-Time Repeat Transplants (Re-Transplantation): Performing second, third, or even fourth renal grafts in patients with obliterated pelvic vascular access, severe retroperitoneal fibrosis, and cumulative allosensitization.
• Infant & Pediatric Kidney Transplantation: National pioneer in pediatric renal replacement surgery, including low-weight pediatric donor kidneys transplanted into adult recipients (dual kidney en bloc transplantation) and infant ESRD recipients requiring delicate microvascular anastomosis.
• Refractory Antibody-Mediated Rejection (AMR): Early biomarker-guided detection and multi-modal therapeutic reversal of acute and chronic active AMR to preserve precious allograft function.

3. Landmark Scientific Research & Clinical Guidelines

Professor Chen bridges bedside surgical mastery with translational molecular immunology, contributing substantially to international transplant literature:

• Transplant Immune Tolerance & Rejection Mechanisms: Leading multiple national investigative projects funded by the National Natural Science Foundation of China (NSFC), elucidating donor-recipient HLA molecular mismatches, non-HLA antigenic targets, and regulatory T-cell induction for long-term allograft tolerance.
• Precision Organ Perfusion & Ischemia-Reperfusion Injury: Investigating machine perfusion strategies and targeted antioxidant signaling cascades to optimize marginal donor organs and reduce delayed graft function (DGF).
• National Guideline Leadership: Serving as a key drafting committee expert for national guidelines on organ donation, immunosuppressive drug monitoring, and pediatric kidney transplantation protocols published by the Chinese Medical Association.

4. Pioneering Innovations in Bedside Practice

Professor Chen's innovations have fundamentally changed clinical paradigms for renal failure patients:

• Microvascular Revascularization in Pediatric Transplants: Refined precision microsurgical techniques for pediatric and infant graft revascularization, preventing vascular thrombosis—a primary cause of early graft loss in young children.
• Tailored Desensitization Framework: Formulated stepped pre-operative desensitization algorithms that have enabled hundreds of heavily sensitized, dialysis-dependent patients to safely receive compatible donor grafts without hyperacute rejection.
• Non-Invasive Allograft Surveillance: Implementing donor-derived cell-free DNA (dd-cfDNA) and urinary mRNA gene expression profiling for subclinical rejection monitoring, drastically reducing the necessity of invasive protocol biopsies.

5. Benchmark Clinical Case Scenarios

Professor Chen’s department is renowned for undertaking high-difficulty cases turned away by conventional transplant centers:

• Case Scenario 1 (Third Kidney Transplant in a Highly Sensitized Recipient): A middle-aged patient with two prior failed allografts and PRA levels exceeding 85% presented with end-stage dialysis complications and extensive pelvic vascular calcification. Professor Chen designed an intensive pre-transplant plasma exchange and targeted biological desensitization strategy, followed by an atypical orthotopic vascular reconstruction. The third transplanted kidney functioned immediately without rejection episodes.
• Case Scenario 2 (Ultra-Low-Weight Pediatric En Bloc Renal Grafting): An adult ESRD recipient received en bloc dual kidneys from an infant donor under Professor Chen’s specialized vascular reconstruction protocol. Both donor kidneys adapted and hypertrophied post-operatively, normalizing the recipient's serum creatinine with long-term graft survival.

6. Accessing Professor Gang Chen for International Patients

For international patients seeking second opinions, immunological risk evaluations, or comprehensive transplant coordination in China, structured clinical preparation is essential:

1. Medical Dossier Compilation: Complete dialysis history, native renal biopsy pathology, previous transplant surgical summaries (if applicable), HLA typing (Class I & II), PRA screening reports, and recent vascular Doppler/CT angiography of the pelvic vessels.
2. Comprehensive Pre-Screening: Clinical review of recipient suitability, infectious disease screening, and cardiovascular clearance to determine surgical and immunological feasibility.
3. Physician Authorization & Expert Consultation: Formal submission of records to Professor Chen’s clinical panel with patient authorization for individualized immunological profiling and procedural recommendations.
4. End-to-End Concierge Coordination: For admitted patients, dedicated coordination encompassing medical visa support, bilingual medical liaison, post-operative immunosuppression titration, and long-term surveillance protocols.

7. Inquire & Request a Clinical Assessment

China Medical Concierge - Shanghai (CMCS) is an independent health management and medical concierge service. We connect international patients and expatriates with leading specialists and premier national academic medical centers across China.

To inquire about case assessments, second opinions, or coordination with Professor Gang Chen’s transplantation team, please reach out directly through our official channels: